Bristol-Myers Squibb Delivers Solid Fourth Quarter Capping a Year Highlighted by New Product Approvals, Continued ...
Bristol-Myers Squibb Company today announced solid financial results for the fourth quarter of 2011. This concludes a year in which the Company received important new product approvals for YERVOY and NULOJIX in both the U.S.

Reviewing the drug class of 2011
The drug class of 2011 was larger than the past few graduating classes. We count over 30 new innovative drugs found among the list of FDA approvals last year. This is in contrast to the 20-something range of the past few years. On the list are some clear breakthrough treatments and a few glimpses of the future of biotech . The specific drugs are listed further below, but first a big picture ...

Genzyme Announces FDA Approval of Framingham Manufacturing Plant
Genzyme, a Sanofi company , announced today that the Food and Drug Administration has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme .